Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
Saved in:
| Title: | Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology. |
|---|---|
| Authors: | Shriver SP; ACS CAN, Washington, DC., Adams D; ACS CAN, Washington, DC., McKelvey BA; Friends of Cancer Research, Washington, DC., McCune JS; City of Hope/Beckman Research Institute Department of Hematologic Malignancies Translational Sciences, Duarte, CA., Miles D; Genentech, San Francisco, CA., Pratt VM; Agena Bioscience, San Diego, CA., Ashcraft K; Invitae Corporation, San Francisco, CA.; YouScript, Houston, TX., McLeod HL; Utah Tech University, St George, UT., Williams H; Color, Burlingame, CA., Fleury ME; ACS CAN, Washington, DC. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 01; Vol. 42 (10), pp. 1181-1192. Date of Electronic Publication: 2024 Feb 22. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
